Biosis, K Seng Seng, KPJ, Pos Malaysia: Malaysia Equity Preview

Shares of the following companies may have unusual price changes in Malaysia trading. Stock symbols are in parentheses, and share prices are as of 5 p.m. in Kuala Lumpur.

Malaysia’s FTSE Bursa Malaysia KLCI Index fell 0.3 percent to 1,570.04. The market will be closed tomorrow for a public holiday.

Biosis Group Bhd. (BGH MK): The personal-care products maker said its Biosis Marketing Sdn. unit received a license from the government to conduct direct selling of health and food supplements. Biosis fell 2.3 percent to 42 sen.

Ibraco Bhd. (IBRA MK): Wee Song Ching, a shareholder of the property developer, bought 3.8 million shares in the company, raising his stake to 20.1 percent, a stock exchange filing showed. The stock was unchanged at 1.30 ringgit.

KPJ Healthcare Bhd. (KPJ MK): The health-care group said it agreed to buy a private hospital and a geriatric care center in Sarawak state for 28.1 million ringgit, according to a company statement. KPJ fell 0.5 percent to 3.76 ringgit.

K Seng Seng Corp. (KSSC MK): The stainless steel tubes and pipes will make its listing debut on the Kuala Lumpur stock exchange. The company sold shares at 57 sen apiece, according to its prospectus.

Pos Malaysia Bhd. (POSM MK): Khazanah Nasional Bhd., Malaysia’s state investment agency, will invite bids this week for its stake in Pos Malaysia, the national postal company, through its advisor CIMB Investment Bank Bhd., Managing Director Azman Mokhtar told reporters in Kuala Lumpur. Pos Malaysia slid 1.7 percent to 3.39 ringgit.

Public Bank Bhd. (PBK MK): The Employees Provident Fund, Malaysia’s biggest pension fund, disclosed net sales of 5.2 million shares in the banking group, trimming its stake to 13 percent, a stock exchange filing showed. Public Bank was unchanged at 13.48 ringgit.

To contact the reporter on this story: Chan Tien Hin in Kuala Lumpur at

To contact the editor responsible for this story: Darren Boey in Hong Kong at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.